Association of meningioma grade with KI-67 proliferative index – an institutional study
DOI:
https://doi.org/10.55629/pakjpathol.v36i2.883Abstract
Objective: To evaluate the frequency and association of Ki-67 labelling index with tumor grade in Meningioma.
Material and Methods: This cross sectional study was conducted at the Department of Histopathology, Liaquat National Hospital Karachi from 1st July 2024 to 31st December 2024. A total of 107 Meningiomas that underwent resection were included in this study. After determining tumor type histologically, immuno-staining for Ki-67 markers was performed. The association between the Ki-67 index and WHO grade of Meningioma was assessed. All data was systematically recorded in a pre-structured proforma.
Result: The average age at diagnosis was 48.99(14.44) years, with female predominance (60.7%). At the time of diagnosis, most tumors were grade 1 (59.8%), and meningothelial Meningioma (55.1%) was the most-common tumor type. A significant association of WHO grade was noted with Ki-67 index. The mean Ki-67 index for WHO grade 3 is significantly (20%) higher than that of grade 1 (3.86%) and grade 2 (7.34%).
Conclusion: Ki-67 was significantly associated with WHO grade (p= <0.001). It is also associated with tumor type, number of mitosis and pattern less or sheet like growth (p= <0.001) helps in understanding tumor behavior and its potential prognosis. We observed that Meningiomas were more prevalent among the female population, and grade 3 Meningiomas showed an increased expression of Ki-67 index. Therefore, Ki-67 index can be used for prognostic stratification of Meningioma.
Keywords: Ki-67 Index, Meningioma, Brain tumor
References
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021. DOI: https://doi.org/10.1002/ijc.33588
Alruwaili AA, De Jesus O. Meningioma. [Updated 2023 Aug 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK560538/
Raghunathan A, Giannini C. Histopathology of Meningiomas. Adv Exp Med Biol. 2023; 1416: 35-45. doi: 10.1007/978-3-031-29750-2_4
Walsh KM. Epidemiology of meningiomas. Handb Clin Neurol. 2020; 169:3-15. DOI: https://doi.org/10.1007/978-3-031-29750-2_4
Thomas RZ, Dalal I. Extracranial metastases of anaplastic meningioma. BJR Case Rep. 2017; 3(2): 20150092.
DOI: https://doi.org/10.1259/bjrcr.20150092
Hanna C, Willman M, Cole D, Mehkri Y, Liu S, Willman J, et al. Review of meningioma diagnosis and management. Egypt J Neurosurg. 2023; 38(1): 16. DOI: https://doi.org/10.1186/s41984-023-00195-z
Mizrachi M, Hartley B, Saleem S, Hintz E, Ziemba Y, Li J, et al.. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection. J Clin Neurosci. 2024; 124: 15-9.
Doi: https://doi.org/10.1016/j.jocn.2024.04.015
Liu N, Song SY, Jiang JB, Wang TJ, Yan CX. The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis. Medicine. 2020; 99(9): e18644.
DOI:https://doi.org/10.1097/md.0000000000018644
Telugu RB, Chowhan AK, Rukmangadha N, Patnayak R, Phaneendra BV, Prasad BC, et al., Histopathological and immunohistochemical evaluation of meningiomas with reference to proliferative markers p53 and Ki-67. J Clin Diag Res. 2016; 10(1): EC15.
DOI: https://doi.org/10.7860/jcdr/2016/15661.7117
Kartheek BV. Clinico-histopathological study of meningiomas in correlation with proliferative index Ki-67. Saudi J Pathol Microbiol, 2020; 5(2): 80-85. DOI:http://dx.doi.org/10.36348/sjpm.2020.v05i02.008
Solanke G, Monappa V, Kudva R. Histopathological spectrum of meningiomas with emphasis on prognostic role of Ki67 labelling index. Iran J Pathol. 2020; 15(3): 197-204. DOI: https://doi.org/10.30699/ijp.2020.107195.2119
Babu S, Uppin SG, Uppin MS, Panigrahi MK, Saradhi V, Bhattacharjee S, et al., Meningiomas: correlation of Ki67 with histological grade. Neurol India. 2011; 59(2):204-7.
DOI: https://doi.org/10.4103/0028-3886.79140
Pugonja R, Bečulić H, Begagić E, Skomorac R, Selimović E, Moranjkić M. Morphometric and Ki-67 proliferative index-related characteristics of meningiomas and their correlation with demographic, clinical, histopathological, and postoperative features. Med Glas. 2024; 21(1): 132-9. DOI: https://doi.org/10.17392/1650-23
Yeldir N, Doğan E, Özer H, Söylemez B, Çelikgün S, Eğilmez R. Ki-67 proliferation index positivity limit (Cut-off) value in meningiomas. Abant Med J. 2023; 12(1): 43-50.
DOI: https://doi.org/10.47493/abantmedj.1177937
Küçükosmanoğlu İ, Karanis Mİ, Ünlü Y, Çöven İ. Evaluation of P57, P53 and Ki67 expression in meningiomas. J Korean Neurosurg Soc. 2022; 65(4): 499-506.
DOI: https://doi.org/10.3340/jkns.2021.0197
Behling F, Fodi C, Wang S, Hempel JM, Hoffmann E, Tabatabai G, et al. Increased proliferation is associated with CNS invasion in meningiomas. J Neuro-oncol. 2021; 155: 247-54.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Armaghana Qamar Khan, Dr Sara Babar, Dr. Yousra Zahid, Dr.Humaira Erum, Dr Atif Ali Hashmi, Dr Naveen Mubarak Faridi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
